August 1, 2025

AMN Healthcare Services Inc (AMN) Stock Analysis: A 42% Potential Upside in the Healthcare Sector

Investors eyeing opportunities within the healthcare sector may find AMN Healthcare Services Inc (NYSE: AMN) an intriguing prospect. With a market capitalization of $700.6 million, this Dallas-based company specializes in..

Avanos Medical, Inc. (AVNS) Stock Analysis: An Investor’s Guide to Navigating Current Challenges in Medical Devices

Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical devices sector, offers innovative solutions across a range of healthcare needs, from digestive health to pain management. Headquartered in..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 136.89% Potential Upside in the Healthcare Sector

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves among investors with a compelling 136.89% potential upside, according to analyst ratings. The healthcare company, specializing in molecular diagnostics, provides innovative test..

ArriVent BioPharma, Inc. (AVBP) Investor Outlook: Exploring a 106% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a dynamic player in the biotechnology sector, is capturing investor attention with its promising potential upside of 106.16%. This clinical-stage biopharmaceutical company is gaining traction..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a 123.98% Potential Upside with Innovative Oncology Solutions

Delcath Systems, Inc. (NASDAQ: DCTH) is capturing the attention of investors with its innovative approach to treating liver cancers and a promising potential upside of 123.98%. As a player in..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unpacking a Potential 109.51% Upside in the Healthcare Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector, is catching the attention of investors with its impressive growth metrics and substantial upside potential. Specializing in treatments..

Taysha Gene Therapies, Inc. (TSHA): Investor Outlook Reveals 204.70% Potential Upside

Investors with an interest in the biotechnology sector should take a closer look at Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a clinical-stage biotech firm with a focus on adeno-associated virus-based..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a Potential 39.84% Upside

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, has caught the attention of investors with its impressive potential upside of 39.84%. Despite the challenges faced..

Amylyx Pharmaceuticals, Inc. (AMLX) Investor Outlook: Exploring a Potential 44.77% Upside Amidst Promising Drug Pipeline

Amylyx Pharmaceuticals, Inc. (AMLX), a clinical-stage biotechnology company based in Cambridge, Massachusetts, is making waves in the healthcare sector with its ambitious approach to neurodegenerative diseases and endocrine conditions. With..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Exploring an 80.72% Potential Upside

Stoke Therapeutics, Inc. (NASDAQ: STOK) is attracting considerable attention from investors due to its innovative approach in the biotechnology sector, focusing on treatments for severe genetic diseases. With a market..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: A Biotech Gem with 132% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) stands at the forefront of the biotechnology industry with a focused commitment to developing innovative therapies for unmet medical needs. Headquartered in Cambridge, Massachusetts, this..

RxSight, Inc. (RXST) Stock Analysis: Exploring a 57% Potential Upside in Medical Devices

RxSight, Inc. (NASDAQ: RXST) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. As a commercial-stage medical technology company, RxSight specializes in innovative solutions for..

Immunome, Inc. (IMNM): Analyst Ratings Suggest a 132.89% Upside Potential in Biotech Stock

Investors eyeing the biotechnology sector may find Immunome, Inc. (NASDAQ: IMNM) an intriguing prospect, especially in light of its substantial potential upside. The clinical-stage biotech company, headquartered in Bothell, Washington,..

Day One Biopharmaceuticals (DAWN) Stock Analysis: An Investor’s Guide to its 291% Potential Upside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) stands out in the biotechnology sector, promising potential that has attracted significant investor interest. With a market cap of approximately $680.14 million, this commercial-stage..

Oculis Holding AG (OCS) Stock Analysis: Uncovering a 111% Potential Upside in the Biotech Sector

For investors seeking opportunities in the dynamic biotechnology sector, Oculis Holding AG (NASDAQ: OCS) presents an intriguing proposition with a remarkable potential upside of 111.37%. This Swiss-based clinical-stage biopharmaceutical company..

Immatics N.V. (IMTX) Stock Analysis: Exploring a Potential 122% Upside in the Biotech Arena

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company, presents an intriguing opportunity for investors willing to navigate the volatile yet promising biotechnology sector. Headquartered in Tübingen, Germany, Immatics focuses on..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a Potential 199% Upside for Biotech Investors

Bicycle Therapeutics plc (NASDAQ: BCYC) presents a captivating opportunity for investors in the biotechnology sector, with analyst ratings suggesting a remarkable potential upside of nearly 200%. As a clinical-stage pharmaceutical..

Beta Bionics, Inc. (BBNX) Investor Outlook: Evaluating a 40.96% Potential Upside in Healthcare Innovation

Beta Bionics, Inc. (NASDAQ: BBNX), a pioneering player in the medical devices industry, is capturing investor attention with its innovative solutions aimed at improving the lives of insulin-dependent individuals. With..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: 116% Potential Upside Sparks Investor Interest

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is catching the eye of investors with an impressive potential upside of 116.35%. This San Diego-based company, specializing in biotechnology, operates within the healthcare..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 77% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS) is drawing attention in the healthcare investment community with its promising growth potential, despite some financial challenges. The company, which specializes in pediatric orthopedic medical devices,..

Search

Funds

August 1, 2025

Search

Funds

August 1, 2025

FTSE 100

Funds